Evidence map›Paper›PMID 39324817›Full record

ArticleAntimicrobial agents and chemotherapy2024

Colonization with resistant bacteria in hospital employees: an epidemiological surveillance and typing study.

Tina Badinski, Salome N Seiffert, Fabian Grässli, Baharak Babouee Flury, Ulrike Besold, Elsbeth Betschon, Michael Biggel, Angela Brucher, Alexia Cusini, Tamara Dörr and 20 more

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Tina BadinskiDivision of Infectious Diseases, Infection Prevention and Travel Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland.ORCID 0000-0002-1319-9835
Salome N SeiffertCentre for Laboratory Medicine St. Gallen, St. Gallen, Switzerland.
Fabian GrässliDivision of Infectious Diseases, Infection Prevention and Travel Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Baharak Babouee FluryDivision of Infectious Diseases, Infection Prevention and Travel Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland.ORCID 0000-0001-8966-5882
Ulrike BesoldGeriatric Clinic St. Gallen, St. Gallen, Switzerland.
Elsbeth BetschonClienia Littenheid, Littenheid, Switzerland.
Michael BiggelVetsuisse Faculty, Institute for Food Safety and Hygiene, University of Zurich, Zurich, Switzerland.ORCID 0000-0002-1337-2132
Angela BrucherPsychiatry Services of the Canton of St. Gallen, St. Gallen, Switzerland.
Alexia CusiniCantonal Hospital of Grisons, Division of Infectious Diseases, Chur, Switzerland.
Tamara DörrDivision of Infectious Diseases, Infection Prevention and Travel Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Adrian EgliInstitute of Medical Microbiology, University of Zurich, Zurich, Switzerland.ORCID 0000-0002-3564-8603
Stephan GoppelVetsuisse Faculty, Institute for Food Safety and Hygiene, University of Zurich, Zurich, Switzerland.
Sabine GüsewellDivision of Infectious Diseases, Infection Prevention and Travel Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Joelle KellerHirslanden Clinic, Zurich, Switzerland.
Matthias von KietzellClinic Hirslanden Stephanshorn, St. Gallen, Switzerland.
J Carsten MöllerCenter for Neurological Rehabilitation, Zihlschlacht, Switzerland.
Oliver NolteCentre for Laboratory Medicine St. Gallen, St. Gallen, Switzerland.
Manuela OrtnerRheintal Werdenberg Sarganserland Hospital Group, Grabs, Switzerland.
Tim RoloffInstitute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
Markus RuettiFuerstenland Toggenburg Hospital Group, Wil, Switzerland.
Matthias SchlegelDivision of Infectious Diseases, Infection Prevention and Travel Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Helena M B Seth-SmithInstitute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
Roger StephanVetsuisse Faculty, Institute for Food Safety and Hygiene, University of Zurich, Zurich, Switzerland.
Reto StockerHirslanden Clinic, Zurich, Switzerland.
Danielle Vuichard-GysinDivision of Infectious Diseases and Hospital Epidemiology, Thurgau Hospital Group, Muensterlingen, Switzerland.
Barbara WilliClinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.ORCID 0000-0002-8010-1180
Stefan P KusterDivision of Infectious Diseases, Infection Prevention and Travel Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Christian R KahlertDivision of Infectious Diseases, Infection Prevention and Travel Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland.ORCID 0000-0002-0784-3276
Philipp KohlerDivision of Infectious Diseases, Infection Prevention and Travel Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland.ORCID 0000-0003-0427-8934
SURPRISE Study Group

Funding

Swiss National Sciences foundation PZ00P3_179919
6 · The paper itself

Abstract

The objective of this study was to determine the prevalence, molecular epidemiology, and risk factors for gut colonization with extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E), carbapenemase-producing Enterobacterales (CPE), and vancomycin-resistant enterococci (VRE) in healthcare workers (HCWs). In September/October 2022, we performed a cross-sectional study among HCW from 14 institutions in Northeastern Switzerland. HCWs reported risk factors for antimicrobial resistance (covering the last 12-24 months) and provided rectal swabs. Swabs were screened for ESBL-E, CPE, and VRE; whole-genome sequencing (WGS) was performed to assess the genetic relatedness. Logistic regression was used to identify occupational and non-occupational risk factors. Among approximately 22,500 employees, 1,209 participated (median age 46 years, 82% female). Prevalences of ESBL-E (

Indexed as

beta-LactamasesVancomycin-Resistant EnterococciAdultAnti-Bacterial AgentsBacterial ProteinsCross-Sectional StudiesEnterobacteriaceaeEpidemiological MonitoringFemaleHealth PersonnelHumansMaleMiddle AgedPersonnel, HospitalPrevalenceRisk FactorsAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamasescarbapenemaseantibiotic resistancecolonizationepidemiologyESBLhealthcare workersoccupationprevalencerisk factorssushi

Identifiers

PMID39324817
PMCPMC11539204

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.